1 Introduction to Research & Analysis Reports
1.1 Pediatrics Respiratory Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatrics Respiratory Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pediatrics Respiratory Drugs Overall Market Size
2.1 Global Pediatrics Respiratory Drugs Market Size: 2022 VS 2029
2.2 Global Pediatrics Respiratory Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pediatrics Respiratory Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Pediatrics Respiratory Drugs Players in Global Market
3.2 Top Global Pediatrics Respiratory Drugs Companies Ranked by Revenue
3.3 Global Pediatrics Respiratory Drugs Revenue by Companies
3.4 Global Pediatrics Respiratory Drugs Sales by Companies
3.5 Global Pediatrics Respiratory Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pediatrics Respiratory Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pediatrics Respiratory Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pediatrics Respiratory Drugs Players in Global Market
3.8.1 List of Global Tier 1 Pediatrics Respiratory Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Pediatrics Respiratory Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pediatrics Respiratory Drugs Market Size Markets, 2022 & 2029
4.1.2 Powder Inhalation
4.1.3 Oral
4.2 By Type – Global Pediatrics Respiratory Drugs Revenue & Forecasts
4.2.1 By Type – Global Pediatrics Respiratory Drugs Revenue, 2018-2023
4.2.2 By Type – Global Pediatrics Respiratory Drugs Revenue, 2024-2029
4.2.3 By Type – Global Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Pediatrics Respiratory Drugs Sales & Forecasts
4.3.1 By Type – Global Pediatrics Respiratory Drugs Sales, 2018-2023
4.3.2 By Type – Global Pediatrics Respiratory Drugs Sales, 2024-2029
4.3.3 By Type – Global Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Pediatrics Respiratory Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pediatrics Respiratory Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Pediatrics Respiratory Drugs Revenue & Forecasts
5.2.1 By Application – Global Pediatrics Respiratory Drugs Revenue, 2018-2023
5.2.2 By Application – Global Pediatrics Respiratory Drugs Revenue, 2024-2029
5.2.3 By Application – Global Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Pediatrics Respiratory Drugs Sales & Forecasts
5.3.1 By Application – Global Pediatrics Respiratory Drugs Sales, 2018-2023
5.3.2 By Application – Global Pediatrics Respiratory Drugs Sales, 2024-2029
5.3.3 By Application – Global Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Pediatrics Respiratory Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pediatrics Respiratory Drugs Market Size, 2022 & 2029
6.2 By Region – Global Pediatrics Respiratory Drugs Revenue & Forecasts
6.2.1 By Region – Global Pediatrics Respiratory Drugs Revenue, 2018-2023
6.2.2 By Region – Global Pediatrics Respiratory Drugs Revenue, 2024-2029
6.2.3 By Region – Global Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Pediatrics Respiratory Drugs Sales & Forecasts
6.3.1 By Region – Global Pediatrics Respiratory Drugs Sales, 2018-2023
6.3.2 By Region – Global Pediatrics Respiratory Drugs Sales, 2024-2029
6.3.3 By Region – Global Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pediatrics Respiratory Drugs Revenue, 2018-2029
6.4.2 By Country – North America Pediatrics Respiratory Drugs Sales, 2018-2029
6.4.3 US Pediatrics Respiratory Drugs Market Size, 2018-2029
6.4.4 Canada Pediatrics Respiratory Drugs Market Size, 2018-2029
6.4.5 Mexico Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pediatrics Respiratory Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Pediatrics Respiratory Drugs Sales, 2018-2029
6.5.3 Germany Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.4 France Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.5 U.K. Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.6 Italy Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.7 Russia Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.9 Benelux Pediatrics Respiratory Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pediatrics Respiratory Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Pediatrics Respiratory Drugs Sales, 2018-2029
6.6.3 China Pediatrics Respiratory Drugs Market Size, 2018-2029
6.6.4 Japan Pediatrics Respiratory Drugs Market Size, 2018-2029
6.6.5 South Korea Pediatrics Respiratory Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Pediatrics Respiratory Drugs Market Size, 2018-2029
6.6.7 India Pediatrics Respiratory Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pediatrics Respiratory Drugs Revenue, 2018-2029
6.7.2 By Country – South America Pediatrics Respiratory Drugs Sales, 2018-2029
6.7.3 Brazil Pediatrics Respiratory Drugs Market Size, 2018-2029
6.7.4 Argentina Pediatrics Respiratory Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pediatrics Respiratory Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pediatrics Respiratory Drugs Sales, 2018-2029
6.8.3 Turkey Pediatrics Respiratory Drugs Market Size, 2018-2029
6.8.4 Israel Pediatrics Respiratory Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Pediatrics Respiratory Drugs Market Size, 2018-2029
6.8.6 UAE Pediatrics Respiratory Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Mylan
7.1.1 Mylan Company Summary
7.1.2 Mylan Business Overview
7.1.3 Mylan Pediatrics Respiratory Drugs Major Product Offerings
7.1.4 Mylan Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Mylan Key News & Latest Developments
7.2 Armstrong Pharmaceuticals
7.2.1 Armstrong Pharmaceuticals Company Summary
7.2.2 Armstrong Pharmaceuticals Business Overview
7.2.3 Armstrong Pharmaceuticals Pediatrics Respiratory Drugs Major Product Offerings
7.2.4 Armstrong Pharmaceuticals Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Armstrong Pharmaceuticals Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Pediatrics Respiratory Drugs Major Product Offerings
7.3.4 GlaxoSmithKline Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Valeant Pharmaceuticals
7.4.1 Valeant Pharmaceuticals Company Summary
7.4.2 Valeant Pharmaceuticals Business Overview
7.4.3 Valeant Pharmaceuticals Pediatrics Respiratory Drugs Major Product Offerings
7.4.4 Valeant Pharmaceuticals Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Valeant Pharmaceuticals Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Pediatrics Respiratory Drugs Major Product Offerings
7.5.4 Merck Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Endo International
7.6.1 Endo International Company Summary
7.6.2 Endo International Business Overview
7.6.3 Endo International Pediatrics Respiratory Drugs Major Product Offerings
7.6.4 Endo International Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Endo International Key News & Latest Developments
7.7 Bauch & Lomb
7.7.1 Bauch & Lomb Company Summary
7.7.2 Bauch & Lomb Business Overview
7.7.3 Bauch & Lomb Pediatrics Respiratory Drugs Major Product Offerings
7.7.4 Bauch & Lomb Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Bauch & Lomb Key News & Latest Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Company Summary
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Pediatrics Respiratory Drugs Major Product Offerings
7.8.4 Boehringer Ingelheim Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Boehringer Ingelheim Key News & Latest Developments
8 Global Pediatrics Respiratory Drugs Production Capacity, Analysis
8.1 Global Pediatrics Respiratory Drugs Production Capacity, 2018-2029
8.2 Pediatrics Respiratory Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Pediatrics Respiratory Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pediatrics Respiratory Drugs Supply Chain Analysis
10.1 Pediatrics Respiratory Drugs Industry Value Chain
10.2 Pediatrics Respiratory Drugs Upstream Market
10.3 Pediatrics Respiratory Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pediatrics Respiratory Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の小児科用呼吸器科医薬品市場予測2023-2029：粉末吸入、経口 |
| 【英語タイトル】Pediatrics Respiratory Drugs Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5882 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：72 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の小児科用呼吸器科医薬品市場規模と予測を収録しています。・世界の小児科用呼吸器科医薬品市場：売上、2018年-2023年、2024年-2029年 ・世界の小児科用呼吸器科医薬品市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の小児科用呼吸器科医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「粉末吸入」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 小児科用呼吸器科医薬品のグローバル主要企業は、Mylan、 Armstrong Pharmaceuticals、 GlaxoSmithKline、 Valeant Pharmaceuticals、 Merck、 Endo International、 Bauch & Lomb、 Boehringer Ingelheimなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、小児科用呼吸器科医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の小児科用呼吸器科医薬品市場：タイプ別、2018年-2023年、2024年-2029年 世界の小児科用呼吸器科医薬品市場：タイプ別市場シェア、2022年 ・粉末吸入、経口 世界の小児科用呼吸器科医薬品市場：用途別、2018年-2023年、2024年-2029年 世界の小児科用呼吸器科医薬品市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界の小児科用呼吸器科医薬品市場：地域・国別、2018年-2023年、2024年-2029年 世界の小児科用呼吸器科医薬品市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における小児科用呼吸器科医薬品のグローバル売上、2018年-2023年 ・主要企業における小児科用呼吸器科医薬品のグローバル売上シェア、2022年 ・主要企業における小児科用呼吸器科医薬品のグローバル販売量、2018年-2023年 ・主要企業における小児科用呼吸器科医薬品のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Mylan、 Armstrong Pharmaceuticals、 GlaxoSmithKline、 Valeant Pharmaceuticals、 Merck、 Endo International、 Bauch & Lomb、 Boehringer Ingelheim ************************************************************* ・調査・分析レポートの概要 小児科用呼吸器科医薬品市場の定義 市場セグメント 世界の小児科用呼吸器科医薬品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の小児科用呼吸器科医薬品市場規模 世界の小児科用呼吸器科医薬品市場規模：2022年 VS 2029年 世界の小児科用呼吸器科医薬品市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの小児科用呼吸器科医薬品の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の小児科用呼吸器科医薬品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：粉末吸入、経口 小児科用呼吸器科医薬品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 小児科用呼吸器科医薬品の用途別グローバル売上・予測 ・地域別市場分析 地域別小児科用呼吸器科医薬品市場規模 2022年と2029年 地域別小児科用呼吸器科医薬品売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Mylan、 Armstrong Pharmaceuticals、 GlaxoSmithKline、 Valeant Pharmaceuticals、 Merck、 Endo International、 Bauch & Lomb、 Boehringer Ingelheim ... |
Paediatric respiratory medicine (PRM) is a multidisciplinary subspecialty within the specialty of paediatrics, involving doctors, nurses, respiratory physiologists, physiotherapists, the child and the parent/caregiver.
This report aims to provide a comprehensive presentation of the global market for Pediatrics Respiratory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatrics Respiratory Drugs. This report contains market size and forecasts of Pediatrics Respiratory Drugs in global, including the following market information:
Global Pediatrics Respiratory Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pediatrics Respiratory Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pediatrics Respiratory Drugs companies in 2022 (%)
The global Pediatrics Respiratory Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Powder Inhalation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pediatrics Respiratory Drugs include Mylan, Armstrong Pharmaceuticals, GlaxoSmithKline, Valeant Pharmaceuticals, Merck, Endo International, Bauch & Lomb and Boehringer Ingelheim, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pediatrics Respiratory Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatrics Respiratory Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pediatrics Respiratory Drugs Market Segment Percentages, by Type, 2022 (%)
Powder Inhalation
Oral
Global Pediatrics Respiratory Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pediatrics Respiratory Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Pediatrics Respiratory Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pediatrics Respiratory Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatrics Respiratory Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pediatrics Respiratory Drugs revenues share in global market, 2022 (%)
Key companies Pediatrics Respiratory Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pediatrics Respiratory Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan
Armstrong Pharmaceuticals
GlaxoSmithKline
Valeant Pharmaceuticals
Merck
Endo International
Bauch & Lomb
Boehringer Ingelheim
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pediatrics Respiratory Drugs, market overview.
Chapter 2: Global Pediatrics Respiratory Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Pediatrics Respiratory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pediatrics Respiratory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pediatrics Respiratory Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の小児科用呼吸器科医薬品市場予測2023-2029：粉末吸入、経口] (コード：MMG23JU5882)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の小児科用呼吸器科医薬品市場予測2023-2029：粉末吸入、経口]についてメールでお問い合わせ |
